Stan J. Van De Graaf

Amsterdam, NH, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 74 publications

Fracture risk under selective and non-selective PPAR agonists in primary biliary cholangitis.

Fracture risk under selective and non-selective PPAR agonists in primary biliary cholangitis.

Journal: Hepatology communications

Published: February 04, 2026

Rapid multiplex liver gene-editing in mice using adeno-associated virus 8 or lipid nanoparticles.

Rapid multiplex liver gene-editing in mice using adeno-associated virus 8 or lipid nanoparticles.

Journal: Molecular therapy. Advances

Published: December 10, 2025

The role of bile salts in itch receptor activation.

The role of bile salts in itch receptor activation.

Journal: Biochimica et biophysica acta. Molecular basis of disease

Published: April 10, 2025

ATP8B1 Deficiency Causes Phosphodiesterase 4-Mediated Glucagon Resistance and Impaired Gluconeogenesis in Mouse and Human Liver.

ATP8B1 Deficiency Causes Phosphodiesterase 4-Mediated Glucagon Resistance and Impaired Gluconeogenesis in Mouse and Human Liver.

Journal: Liver international : official journal of the International Association for the Study of the Liver

Published: March 10, 2025

NTCP ubiquitination enables HBV infection.

NTCP ubiquitination enables HBV infection.

Journal: JHEP reports : innovation in hepatology

Published: October 09, 2024

Getting in the zone: Metabolite transport across liver zones.

Getting in the zone: Metabolite transport across liver zones.

Journal: Acta physiologica (Oxford, England)

Published: July 15, 2024

Preclinical targeting of liver fibrosis with a 89Zr-labeled Fibrobody® directed against platelet derived growth factor receptor-β.

Preclinical targeting of liver fibrosis with a 89Zr-labeled Fibrobody® directed against platelet derived growth factor receptor-β.

Journal: European journal of nuclear medicine and molecular imaging

Published: April 17, 2024

Maladaptive regeneration and metabolic dysfunction associated steatotic liver disease: Common mechanisms and potential therapeutic targets.

Maladaptive regeneration and metabolic dysfunction associated steatotic liver disease: Common mechanisms and potential therapeutic targets.

Journal: Biochemical pharmacology

Published: February 29, 2024

Targeting bile salt homeostasis in biliary diseases.

Targeting bile salt homeostasis in biliary diseases.

Journal: Current opinion in gastroenterology

Published: January 17, 2024

Inhibition of hepatic bile salt uptake by Bulevirtide reduces atherosclerosis in Oatp1a1-/-Ldlr-/- mice.

Inhibition of hepatic bile salt uptake by Bulevirtide reduces atherosclerosis in Oatp1a1-/-Ldlr-/- mice.

Journal: Journal of lipid research

Published: November 10, 2023

The Phospholipid Flippase ATP8B1 is Involved in the Pathogenesis of Ulcerative Colitis via Establishment of Intestinal Barrier Function.

The Phospholipid Flippase ATP8B1 is Involved in the Pathogenesis of Ulcerative Colitis via Establishment of Intestinal Barrier Function.

Journal: Journal of Crohn's & colitis

Published: November 07, 2023

Bile salt signaling and bile salt-based therapies in cardiometabolic disease.

Bile salt signaling and bile salt-based therapies in cardiometabolic disease.

Journal: Clinical science (London, England : 1979)

Published: August 18, 2023

Showing 1-12 of 74

Last Updated: 09/26/2026